We showed that treatment with tamoxifen, fulvestrant and palbociclib increased the percentage of G1-arrested (Supplementary Fig. 1a) and apoptotic (Supplementary Fig. 1b) ER+ breast cancer cells. The gene discussed is ESR1; the disease is breast carcinoma.